Prosecution Insights
Last updated: May 29, 2026

Examiner: DELEO, VICTORIA LYNN

Tech Center 1600 • Art Units: 1662

This examiner grants 38% of resolved cases

Performance Statistics

37.5%
Allow Rate
-22.5% vs TC avg
63
Total Applications
-39.1%
Interview Lift
911
Avg Prosecution Days
Based on 24 resolved cases, 2023–2026

Rejection Statute Breakdown

2.3%
§101 Eligibility
8.6%
§102 Novelty
50.0%
§103 Obviousness
17.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18290113 TISSUE-CULTURE INDEPENDENT GENE EDITING OF CELLS BY A LONG-DISTANCE RNA TRANSPORT SYSTEM Final Rejection Texas Tech University System
18271339 Soybean Engineered Resistance Non-Final OA Syngenta Crop Protection AG
18268280 CREATE HUANGLONGBING TOLERANCE BY SILENCING A CITRUS NEGATIVE IMMUNE REGULATOR Final Rejection UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
18007001 REMOVABLE PLANT TRANSGENIC LOCI WITH COGNATE GUIDE RNA RECOGNITION SITES Non-Final OA INARI AGRICULTURE TECHNOLOGY, INC.
18673456 ALBUGO CANDIDA RESISTANCE GENE Non-Final OA RIJK ZWAAN ZAADTEELT EN ZAADHANDEL B.V.
18565025 NOVEL BRAZZEIN PRODUCTION SYSTEM AND METHODS Non-Final OA The Coca-Cola Company
18037522 METHOD FOR SELECTING OR IDENTIFYING A BRASSICA NAPUS PLANT HAVING RESISTANCE TO FUNGAL PATHOGEN Non-Final OA KWS SAAT SE & Co. KGaA
18692895 TRANSFORMING CANNABACEAE CELLS Non-Final OA Cibus US LLC
18006423 PLANT REGULATORY ELEMENTS AND METHODS OF USE THEREOF Final Rejection PIONEER HI-BRED INTERNATIONAL, INC.
18000067 LARGE SCALE GENOME MANIPULATION Non-Final OA PIONEER HI-BRED INTERNATIONAL, INC.
18557777 USE OF PROTOPORPHYRINOGEN OXIDASE Non-Final OA BEIJING DABEINONG BIOTECHNOLOGY CO., LTD.
18268409 PROMOTING REGENERATION AND TRANSFORMATION IN BETA VULGARIS Non-Final OA STICHTING WAGENINGEN RESEARCH
18354694 PSEUDOMONAS SYRINGAE PV. TABACI-RESISTANT SHORT WZ INTROGRESSION SEGMENT, USE, AND SCREENING METHOD THEREOF Non-Final OA Yunnan Academy Of Tobacco Agricultural Sciences

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month